Cue Biopharma, Inc. (CUE)

28.18 +0.02 (+0.07%) USD  |  NASDAQ  |  Aug 28, 16:00
28.18 0.00 (0.00%) After-Hours: 20:00
More

Cue Biopharma Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 28, 2026 --
August 25, 2026 --
August 17, 2026 --
May 15, 2026 --
December 31, 2025 --
November 28, 2025 --
November 18, 2025 --
November 17, 2025 --
November 13, 2025 --
August 25, 2025 --
August 22, 2025 --
August 13, 2025 --
May 23, 2025 --
May 19, 2025 --
April 21, 2025 --
April 15, 2025 --
April 02, 2025 --
Date Value
April 01, 2025 --
March 31, 2025 --
November 18, 2024 --
November 15, 2024 --
November 11, 2024 --
September 30, 2024 --
August 20, 2024 --
July 29, 2024 --
July 26, 2024 --
July 25, 2024 --
June 30, 2024 --
June 06, 2024 --
May 16, 2024 --
May 10, 2024 --
April 09, 2024 --
April 03, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Equillium, Inc. Upgrade
Legend Biotech Corp. Upgrade
Nurix Therapeutics, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade